Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis [3]

Internal Medicine Journal

Volumn 37, Issue 7, 2007, Pages 508-509

  Jamboti, J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BIOACCUMULATION; CASE REPORT; CHRONIC KIDNEY DISEASE; CONTRAST RADIOGRAPHY; DISEASE PREDISPOSITION; DRUG ACCUMULATION; DRUG HALF LIFE; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROGENIC FIBROSING DERMOPATHY; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC DISEASE;

FIBROSIS; GADOLINIUM; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; RADIOPHARMACEUTICALS; SKIN DISEASES;

EID: 34249809114     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01413.x     Document Type: Letter

References (7)

1. Cheung PP, Dorai Raj AK. Nephrogenic fibrosing dermopathy: a new clinical entity mimicking scleroderma. Intern Med J 2007 37 : 139 41.
2. Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous amulatory peritoneal dialysis. Acad Radiol 1998 5 : 491 502.
3. High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007 56 : 21 6.
4. Okada S, Katagiri K, Kumazaki T, Yokoyama H et al. Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiologica 2001 42 : 339 41.
5. Deo A, Fogel M, Cowper SE. Nephrogenic Systemic Fibrosis: A population study examining the relationship of disease development to Gadolinium exposure. Clin J Am Soc Nephrol 2007 2 : 264 7.
6. Public Health Advisory. Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy. FDA Medwatch website 2006 Dec 21 Available from URL : http://www.fda.gov/medwatch
7. Kuo PH, Kanal E, Alu-Alfa AK, Cowper SE (editorial). Radiology 2007 242 : 647 9.